Phenobarbital decreases hepatocyte EGF receptor expression independent of protein kinase C activation

This publication has 31 references indexed in Scilit:

• Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferation
  Carcinogenesis: Integrative Cancer Research, 1988
• The Hepatocarcinogen Hydroxy‐acetylaminofluorene Causes Decreased Binding of Epidermal Growth Factor to Rat Hepatocytes in Primary Culture
  Annals of the New York Academy of Sciences, 1987
• Hormone- and tumor promoter-induced activation or membrane association of protein kinase C in intact cells
  Published by Elsevier ,1987
• Phorbol esters, but not epidermal growth factor or insulin, rapidly decrease soluble protein kinase C activity in rat hepatocytes
  Biochemical and Biophysical Research Communications, 1986
• Chronic treatment with phenobarbital decreases the expression of rat liver EGF and insulin receptors
  Biochemical and Biophysical Research Communications, 1986
• The glucocorticoid dexamethasone and the tumor-promoting artificial sweetener saccharin stimulate protein kinase C from T51B rat liver cells
  Biochemical and Biophysical Research Communications, 1986
• Activation of calcium-activated, phospholipid-dependent protein kinase (protein kinase C) by new classes of tumor promoters: Teleocidin and debromoaplysiatoxin
  Biochemical and Biophysical Research Communications, 1984
• Molecular aspects of growth factor action: Receptors and intracellular signals
  The Journal of Pathology, 1983
• Teleocidin B inhibits binding of epidermal growth factor to cellular receptors probably by the same mechanism as phorbol esters
  Biochemical and Biophysical Research Communications, 1980
• Biologically active phorbol esters specifically alter affinity of epidermal growth factor membrane receptors
  Nature, 1979